Press release
Desmoid Tumors Pipeline Appears Robust With 4+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
Discover the latest drugs and treatment options in the Desmoid Tumors Pipeline. Dive into DelveInsight's comprehensive report today! @ Desmoid Tumors Pipeline Outlook [https://www.delveinsight.com/sample-request/desmoid-tumors-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Desmoid Tumors Pipeline Report
* In May 2025, Nam Bui announced a study of this protocol is treatment. Systemic therapy with oral study agent, nirogacestat, will be given for 3 cycles (1 cycle = 28 days) followed by a single cryoablation procedure between Cycles 3 and 4, and then continued nirogacestat for Cycles 4 through 26. Treatment with nirogacestat may continue via this study for up to 24 months (26 cycles of treatment), unless there is progression of disease, intolerance, subject withdraws their consent, start of a new anticancer therapy, or until Subject Study Completion or Termination occurs.
* DelveInsight's Desmoid Tumors Pipeline report depicts a robust space with 4+ active players working to develop 4+ pipeline therapies for Desmoid Tumors treatment.
* The leading Desmoid Tumors Companies such as Immunome, Iterion Therapeutics and others.
* Promising Desmoid Tumors Pipeline Therapies such as AL102, Nirogacestat, Cryoablation, Sirolimus, Imatinib, FOG-001, mFOLFOX-6, REC-4881 and others.
Stay ahead with the most recent pipeline outlook for Desmoid Tumors. Get insights into clinical trials, emerging therapies, and leading companies with DelveInsight @ Desmoid Tumors Treatment Drugs [https://www.delveinsight.com/sample-request/desmoid-tumors-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Desmoid Tumors Emerging Drugs Profile
* AL102: Immunome
AL102 is an investigational small molecule gamma secretase inhibitor currently being evaluated for the treatment of desmoid tumors - a debilitating soft tissue malignancy. AL102 is a potential once-daily oral treatment for desmoid tumors. Currently, the drug is in Phase III stage of its clinical trial for the treatment of Desmoid Tumors.
The Desmoid Tumors Pipeline Report Provides Insights into
* The report provides detailed insights about companies that are developing therapies for the treatment of Desmoid Tumors with aggregate therapies developed by each company for the same.
* It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Desmoid Tumors Treatment.
* Desmoid Tumors Companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
* Desmoid Tumors Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
* Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Desmoid Tumors market
Explore groundbreaking therapies and clinical trials in the Desmoid Tumors Marketed and Pipeline Drugs. Access DelveInsight's detailed report now! @ New Desmoid Tumors Drugs [https://www.delveinsight.com/sample-request/desmoid-tumors-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Desmoid Tumors Companies
Immunome, Iterion Therapeutics and others.
Desmoid Tumors pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
* Oral
* Intravenous
* Subcutaneous
* Parenteral
* Topical
Desmoid Tumors Products have been categorized under various Molecule types such as
* Recombinant fusion proteins
* Small molecule
* Monoclonal antibody
* Peptide
* Polymer
* Gene therapy
Unveil the future of Desmoid Tumors Treatment. Learn about new drugs, pipeline developments, and key companies with DelveInsight's expert analysis @ Desmoid Tumors Market Drivers and Barriers [https://www.delveinsight.com/sample-request/desmoid-tumors-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Desmoid Tumors Pipeline Report
* Coverage- Global
* Desmoid Tumors Companies- Immunome, Iterion Therapeutics and others.
* Promising Desmoid Tumors Pipeline Therapies- AL102, Nirogacestat, Cryoablation, Sirolimus, Imatinib, FOG-001, mFOLFOX-6, REC-4881 and others.
* Desmoid Tumors Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
* Desmoid Tumors Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
Get the latest on Desmoid Tumors Therapies and clinical trials. Download DelveInsight's in-depth pipeline report today! @ Desmoid Tumors Companies, Key Products and Unmet Needs [https://www.delveinsight.com/sample-request/desmoid-tumors-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Contents
* Introduction
* Executive Summary
* Desmoid Tumors: Overview
* Pipeline Therapeutics
* Therapeutic Assessment
* Desmoid Tumors - DelveInsight's Analytical Perspective
* Late Stage Products (Phase III)
* AL102: Immunome
* Mid-Stage Products (Phase II/III)
* Drug name: Company name
* Drug profiles in the detailed report.....
* Early Stage Products (Phase I)
* Drug name: Company name
* Drug profiles in the detailed report.....
* Pre-clinical and Discovery Stage Products
* Drug name: Company name
* Drug profiles in the detailed report.....
* Inactive Products
* Desmoid Tumors Key Companies
* Desmoid Tumors Key Products
* Desmoid Tumors- Unmet Needs
* Desmoid Tumors- Market Drivers and Barriers
* Desmoid Tumors- Future Perspectives and Conclusion
* Desmoid Tumors Analyst Views
* Desmoid Tumors Key Companies
* Appendix
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=desmoid-tumors-pipeline-appears-robust-with-4-key-pharma-companies-actively-working-in-the-therapeutics-segment-delveinsight]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/desmoid-tumors-pipeline-insight
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Desmoid Tumors Pipeline Appears Robust With 4+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight here
News-ID: 4043522 • Views: …
More Releases from ABNewswire
Maple and Mocha Coffee's Holiday Campaign Brings Clean Water to Kirinda Village …
Emerging specialty roaster Maple and Mocha Coffee reports strong holiday season response to its Vermont Maple Pecan blend and clean water initiative. The company's commitment to donating 10% of sales to the Kyempapu Water Project resonates with gift-buyers seeking purpose-driven purchases during the festive season.
The intersection of holiday traditions and social responsibility has found a sweet spot in Maple and Mocha Coffee's Vermont Maple Pecan blend, as conscious consumers embrace…
Female Entrepreneur Disrupts Fashion Industry with Boutique Solving Women's Holi …
Fabulous Knits founder transforms personal shopping frustrations into thriving online boutique serving women 25-65 with unique, well-fitting fashion. The company's rapid growth in under two years demonstrates strong market demand for alternatives to generic retail offerings during peak holiday shopping periods.
In an industry dominated by mass-market retailers and unpredictable overseas suppliers, Fabulous Knits stands as a testament to the power of understanding and solving real customer problems. Founded by a…
Sarasota General Contractor Aegis Construction Services Responds to Growing Hurr …
Sarasota-based Aegis Construction Services expands hurricane restoration work, providing specialized foundation repairs and concrete services following the 2024 storm season across Florida's Gulf Coast.
Aegis Construction Services [http://www.aegisfl.com/] has seen increased demand for specialized construction services following the 2024 hurricane season that impacted Florida's Gulf Coast. The Sarasota-based company has been actively working on structural repairs and complete rebuilds for properties damaged by back-to-back storms.
Hurricane Recovery Projects Highlight Expertise
The company recently…
Uniquely Unique Building And Remodeling LLC Expands Kitchen Remodeling Services …
Uniquely Unique Building And Remodeling LLC expands renovation services in Flat Rock, MI, offering transparent five-step processes for kitchen and bathroom projects with professional design and project management support.
Uniquely Unique Building And Remodeling LLC Expands Kitchen Remodeling Services for Flat Rock Homeowners
A local construction company is changing how homeowners approach home improvements. Uniquely Unique Building And Remodeling LLC has announced an expansion of residential renovation services, focusing on transparent processes…
More Releases for Desmoid
Desmoid Tumors Market to Expand Significantly by 2034, States DelveInsight Repor …
DelveInsight's "Desmoid Tumors Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Desmoid Tumors, historical and forecasted epidemiology as well as the Desmoid Tumors market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Desmoid Tumors market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Desmoid Tumors Market Forecast
https://www.delveinsight.com/sample-request/desmoid-tumors-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key…
Rising Global Cancer Incidence Fuels Growth In The Desmoid Tumor Market: The Dri …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Desmoid Tumors Market Size Growth Forecast: What to Expect by 2025?
The valuation of the desmoid tumors market has experienced significant expansion recently, projected to increase from $2.97 billion in the year 2024 to reach $3.15 billion by 2025, reflecting a compound annual growth rate of 6.3%; this upward…
Desmoid Tumors Market Future Business Scope Analysis Report, Marketing Strategy, …
Introduction
The Desmoid Tumors Market focuses on a rare, locally aggressive, but non-metastatic type of soft tissue tumor that arises from fibroblasts. Also known as aggressive fibromatosis, desmoid tumors can occur anywhere in the body, but are most common in the abdomen, shoulder, and limbs. Although they do not spread to distant organs, they can cause significant morbidity due to local invasion and recurrence.
Over the past decade, treatment strategies have evolved…
Top Factor Driving Desmoid Tumors Market Growth in 2025: Rising Global Cancer In …
How Big Is the Desmoid Tumors Market Expected to Be, and What Will Its Growth Rate Be?
The desmoid tumors market is set to grow from $2.97 billion in 2024 to $3.18 billion in 2025, at a CAGR of 7.3%. Growth is driven by advancements in medical imaging, genetic research, surgical innovations, and increased awareness and education on these tumors.
The desmoid tumors market is forecast to grow strongly, reaching $4.13 billion…
Top Factor Driving Desmoid Tumors Market Growth in 2025: Rising Global Cancer In …
How Big Is the Desmoid Tumors Market Expected to Be, and What Will Its Growth Rate Be?
The desmoid tumors market is set to grow from $2.97 billion in 2024 to $3.18 billion in 2025, at a CAGR of 7.3%. Growth is driven by advancements in medical imaging, genetic research, surgical innovations, and increased awareness and education on these tumors.
The desmoid tumors market is forecast to grow strongly, reaching $4.13 billion…
Desmoid Tumors Market Strategies 2024-2033: Segments, Analysis, Trends, Opportun …
"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Desmoid Tumors Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $3.84 billion In 2028 At…
